Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation (Q48824117)

From Wikidata

Jump to navigation Jump to search

scientific article published on 4 December 2013

Language	Label	Description	Also known as
English	Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation	scientific article published on 4 December 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

0 references

phosphorylation

0 references

frontotemporal dementia

1 reference

based on heuristic

inferred from title

Marc Suárez-Calvet

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

Daniel A. Alcolea

8

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

José Luis Molinuevo

14

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

Jordi Clarimón

16

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

Christine Van Broeckhoven

13

object named as

Christine Van Broeckhoven

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

Julie van der Zee

11

object named as

Julie van der Zee

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

10

object named as

Isidre Ferrer

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

Albert Llado Plarrumani

3

object named as

Albert Lladó

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

Oriol Dols Icardo

2

object named as

Oriol Dols-Icardo

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

12

object named as

Lubina Dillen

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

17

object named as

Alberto Lleó

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

author name string

Raquel Sánchez-Valle

4

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

Isabel Hernández

5

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

Guillermo Amer

6

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

Sofía Antón-Aguirre

7

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

Juan Fortea

9

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

Rafael Blesa

15

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

language of work or name

0 references

publication date

4 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

85

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

6

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

684-691

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

Frontotemporal lobar degeneration: current concepts in the light of recent advances

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Familial aggregation in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Biomarkers in frontotemporal lobar degenerations--progress and challenges

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

PICOGEN: five years experience with a genetic counselling program for dementia.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Classification of primary progressive aphasia and its variants

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Expansion mutation in C9ORF72 does not influence plasma progranulin levels in frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Comparison of 2 diagnostic criteria for the behavioral variant of frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Beta-secretase activity increases with aging in human, monkey, and mouse brain.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Neuropathological background of phenotypical variability in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Serum biomarker for progranulin-associated frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

CSF biomarkers in frontotemporal lobar degeneration with known pathology

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer's, but not in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305972

21 January 2018

Identifiers

10.1136/JNNP-2013-305972

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24309270

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48824117&oldid=2211035292"